DOC Updates

Duración total:21 h 32 min
What's Next—Hypercortisolism in Uncontrolled Diabetes and Resistant Hypertension: When and How to Test for Excess Cortisol
DOC Updates
31:33
Continuous Ketone Monitoring in People with Diabetes—Part 2
DOC Updates
28:22
What's Next: CKD in People with Diabetes—A Case-Based Discussion
DOC Updates
42:49
CGMs & Non-Insulin-Treated T2D, Islet Autoantibody Screening & T1D, Semaglutide CVD Risk Reduction, and more!
DOC Updates
31:52
What's Next—Amylin-based Therapies
DOC Updates
27:31
Variability in Autoantibody Ordering Patterns & Diabetes Misclassification and Determinants of Cognitive Change Over 1 Year in Older Adults With T1D
DOC Updates
46:29
Hypertension Part 3—Advanced Hypertension Management: Challenging Cases
DOC Updates
35:31
Beyond Diabetes and Obesity: Expanding Applications of Incretin Biology
DOC Updates
32:05
T2D & Bone Density, Microarchitecture, & Strength; Early Weight Loss, Glucose Tolerance, & Long-Term Mortality/CVD Risk; and more!
DOC Updates
32:44
Sarcopenic Obesity & T2D, Cumulative BMI Burden From Childhood to Adulthood & Risk of Metabolic Multimorbidity, and more!
DOC Updates
24:37
Hypertension Part 2—Advanced Hypertension Management: Uncontrolled and Resistant Hypertension and the Importance of Aldosterone
DOC Updates
39:38
Special Edition: Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH)
DOC Updates
22:38
Special Edition: Evidence-Based Strategies for Weight Loss and Long-Term Weight Maintenance
DOC Updates
32:04
Special Edition: What's Next—The Role of Health Systems in Managing CKD Associated with T1D & T2D
DOC Updates
33:00
Katherine Tuttle on SGLT2s & CKD in T2D, Alexander Turchin on medications after Metformin, and High vs. Low CVD Risk, the ADA's statement on employment and diabetes, and more!
DOC Updates
35:49
Impact of Finerenone on Albuminuria in T1D, National Trends in Out-of-Pocket Cost for Glucose-Lowering Drugs, and more!
DOC Updates
32:19
Hypertension Part I—Overview and Management
DOC Updates
33:38
Special Edition: Highlights from the ADA's 2026 Scientific Sessions
DOC Updates
44:41
Special Edition: Lp(a) & CV Risk
DOC Updates
34:06
Special Edition: What's Next—Once-Weekly Insulins—Mechanisms and Practical Considerations
DOC Updates
25:40
Special Edition: What's Next—CKD in Type 1 Diabetes—An Urgent Need for Therapies
DOC Updates
28:18
Efficacy and safety of CagriSema & Retatrutide, CGM benefits beyond T2D, & more!
DOC Updates
34:30
Special Edition: Medications in the Pipeline for Cardiometabolic Disease
DOC Updates
25:10
Special Edition: The Diabetes, Obesity, and CardioMetabolic CARE Symposium—The Cost of Obesity and Its Treatment
DOC Updates
29:56
Anna Kahkoska & Joshua Niznik on Patient Portal Messages and Older Adults with T2D, Esben Thyssen Vestergaard on Clinic for Athletes with T1D, and more!
DOC Updates
38:08
Food coloring additives & T2D, automated insulin delivery systems in T2D, and more!
DOC Updates
38:41
Special Edition: Obesity Processes and PATHWEIGH for Obesity Care
DOC Updates
30:00
Special Edition: Obesity—The Changing Landscape
DOC Updates
33:31
Special Edition: What's Next—Cortisol, Metabolism & Future Innovation, Part 4
DOC Updates
27:06
Special Edition: What's Next—Cardiovascular Risk in CKD—The Overlooked Burden
DOC Updates
30:56
Special Edition: What's Next—Once-Weekly Insulin
DOC Updates
20:46
Associations between GLP-1 Receptor Agonists and Ischemic Optic Neuropathy, Tirzepetide vs. Dulaglutide or Semaglutide on major cardiovascular events in T2D, and more!
DOC Updates
36:59
Special Edition: What's Next—Emerging Technologies for People with Diabetes
DOC Updates
35:05
The Points of CARE - James Gavin & Naunihal Virdi on CGM Use in Noninsulin-Treated Patients, Ivy Shi & Dhruv Kazi on GLP-1 RA Eligibility in Reproductive-Age US Women, and Eva Tseng on START Diabetes
DOC Updates
30:30
Special Edition: Continuous Ketone Monitoring—Part 1
DOC Updates
26:22
Diabetes Core Update – April 2026
DOC Updates
26:11
Special Edition - Obesity as a Chronic Disease - Treatment Approach March 2026
DOC Updates
40:03
Special Edition: What's Next—Understanding Chronic Kidney Disease in People with Diabetes—Epidemiology, Pathophysiology, and Detection - March 2026
DOC Updates
26:34
Special Edition - Diabetes and Primary Care March 2026
DOC Updates
32:50
Diabetes Core Update March 2026
DOC Updates
33:52